Chapter 2 - ISABELLA’S ORDER
Matteo Moretti arrived at the estate before anyone called him.
That was the first problem.
He came through the front hall wearing a charcoal suit and the irritated expression of a man inconvenienced by someone else’s emergency.
Vincent was in the library with outside counsel when Enzo announced him.
“Who told him?”
Vincent asked.
Enzo looked displeased.
“I didn’t.”
Claire sat upstairs with Lucas and Leo in the east cottage.
She would hear the details later.
But the first fracture in the Moretti family happened without her.
Matteo walked into the library.
“What the hell did you do to the HVAC?”
Vincent did not stand.
“How did you know?”
Matteo stopped.
A mistake.
Then recovered.
“Facilities called me.”
“Which facilities employee?”
“Carlo Bianchi.”
Vincent looked at Enzo.
Enzo checked his phone.
“Bianchi was told only that the north residential branch was shut down for inspection. Not why.”
Matteo’s jaw tightened.
Vincent pushed a photograph across the table.
The canister housing.
Matteo glanced once.
Too quickly.
“You recognize it.”
“It’s old mold-remediation equipment.”
“Why is it feeding my sons’ bedrooms?”
“It shouldn’t be.”
“Who installed it?”
Matteo sat.
“Years ago? Aurelia.”
“Who owns Aurelia Indoor Health?”
Silence.
Outside counsel, Helen Ward, answered from a file.
“Aurelia was dissolved two years ago. It was owned through Vela Environmental Ventures.”
Vincent knew Vela.
A Moretti family investment vehicle.
He looked at Matteo.
“How much?”
Matteo:
“What?”
“How much of Vela did you own?”
“Thirty percent.”
There.
Then Vincent asked:
“Who owned the rest?”
Matteo rubbed jaw.
“Your father held twenty. Two outside investors. Harrison had options.”
Dr. Blake.
A physician with equity in the company supplying a “treatment” inside his patients’ bedrooms.
Conflict.
Then Matteo said:
“It was not a drug. It was an air-quality product.”
Helen Ward:
“What product?”
“An antimicrobial vapor system.”
Claire would later insist everyone stop calling it therapy.
It was equipment.
Not medicine.
Matteo continued.
“Aurelia developed a system for mold remediation in empty commercial properties. Isabella became obsessed with mold after the twins had respiratory issues as toddlers. Harrison suggested a controlled residential adaptation.”
Vincent’s voice dropped.
“Was it approved for that?”
Matteo did not answer.
Helen did.
“No.”
Then:
“Did Isabella know?”
“At first she knew it was experimental.”
“At first?”
Matteo looked away.
That phrase mattered.
Three years before Isabella died, when Lucas and Leo were two, a leak in the mansion roof produced mold behind a nursery wall.
Remediation happened.
Blake recommended Aurelia equipment for forty-eight hours while family stayed elsewhere.
That use may have been appropriate depending product and protocols.
Then Aurelia proposed “maintenance cartridges” that would release very low levels of proprietary antimicrobial compounds into supply air.
Continuous.
Isabella agreed for one month because Blake told her it had been safety tested.
No written regulatory approval.
No independent pediatric review.
Then she stopped.
Why?
She smelled the same sweet chemical odor Claire had noticed.
The boys developed headaches and nose irritation.
Isabella demanded removal.
Evelyn remembered.
The canisters were supposedly disconnected.
Then Isabella wrote an order in household file:
NO AURELIA DEVICES OR CHEMICAL AIR TREATMENT IN RESIDENTIAL AREAS.
Signed.
Dated.
Vincent stared at copy.
He had never seen.
Where had it been?
Household medical binder.
Managed by Blake and Mrs. Harper.
Then system was reactivated eighteen months ago.
Exactly when worsening began.
Who authorized?
Maintenance ticket:
NORTH CHILDREN’S WING AIR QUALITY UPGRADE.
Requested by Matteo.
Approved by Blake.
Installed by Carlo Bianchi’s team under a vendor called Meridian Building Science.
Meridian was a shell subcontractor partly owned by Aurelia’s former operations director.
Why reactivate a discontinued system?
Matteo’s answer:
“Mold concern.”
Evidence?
None.
No positive mold test.
No water leak.
No complaint from Vincent.
Then why?
Matteo eventually admitted:
Aurelia’s patents had been sold to a large real-estate services company.
The buyer had withheld final payment until the technology showed a successful “long-duration occupied environment demonstration.”
Vincent stood.
“My children were a demonstration.”
“No.”
Matteo raised both hands.
“That was not how I saw it.”
“How did you see it?”
“A house we controlled. A system already installed. Harrison said the concentrations were safe.”
Helen asked:
“Did the buyer know the occupied site involved children?”
Matteo looked down.
“No.”
There.
Then:
“Did Vincent know?”
“No.”
“Did Isabella’s written prohibition remain in file?”
“I didn’t know about that.”
Maybe true.
Then Blake.
He had approved.
Why?
Consulting compensation tied to sale milestone:
$900,000 if validation completed.
Matteo stood to earn several million through Vela.
Money.
Not plan to harm.
Reckless human experimentation.
Then Claire joined later after boys asleep.
Vincent told her.
She did not say:
I knew it.
She asked:
“What did the toxicologist find?”
Preliminary labs were not back.
Symptoms alone could not prove.
Good.
Then Dr. Grant called.
The canisters contained a mixture of volatile industrial remediation compounds.
He refused to speculate on exact health effects until lab identification.
Some components were known irritants.
Some not intended for chronic residential inhalation.
The formulation had changed since original product.
No one in house knew dose or release rate.
That uncertainty was enough to keep rooms sealed.
Then Claire asked:
“Could this explain everything?”
Dr. Chen:
“It could explain some or much of the symptom pattern. We need objective exposure data and we need to rule out other disease.”
Important.
No instant diagnosis.
Then Vincent asked:
“What happens now?”
“Keep them away from the source. Support hydration and nutrition. Repeat labs. Track symptoms. No unproven detox treatments.”
Good.
Then Blake returned with lawyer.
He wanted access to patient records.
Vincent said no.
Dr. Chen corrected:
“Patient records belong under appropriate medical access rules, not your permission alone.”
Vincent looked.
Right.
Parents had rights, but clinicians too.
Then Blake’s explanation.
He admitted financial interest in Aurelia.
Said Vincent’s father had known.
Said Isabella knew at first.
Denied knowing system had been reactivated at concentrations above original settings.
That phrase.
“Above original settings?”
Vincent asked.
Blake went silent.
Helen:
“How would you know settings changed?”
Blake’s lawyer touched his arm.
Too late.
Blake had seen monitoring data.
Where?
Aurelia cloud dashboard shut down after dissolution but mirrored through Meridian.
He had logins.
He had reviewed release-rate charts repeatedly over eighteen months.
And he had said nothing while the twins weakened.
Why?
He claimed he believed measured output remained below industrial occupational thresholds.
Dr. Chen later nearly exploded.
“Occupational limits for healthy adults are not pediatric residential safety standards.”
Exactly.
Then Blake said he had ordered bloodwork.
Which tests?
Not for the relevant compounds.
Why?
“No validated clinical reference range for chronic low-level residential exposure.”
So he chose not to disclose possibility.
That was not the same as no evidence.
Then Vincent asked:
“Did you ever tell another specialist about the system?”
“No.”
There.
Eleven months.
Millions.
Dozens of doctors.
All diagnosing without one environmental fact.
Blake had controlled the history.
Then Mrs. Harper spoke from doorway.
“I tried once.”
Everyone turned.
She held an old envelope.
“I wrote Mrs. Moretti’s order down after she died because Dr. Blake told me to remove it from the active binder.”
Blake stared.
Evelyn continued.
“He said it was outdated.”
“Did you remove it?”
“Yes.”
“Why keep a copy?”
Evelyn’s hands shook.
“Because Mrs. Moretti made me promise.”
Then she looked at Vincent.
“And because I was afraid.”
“Of Blake?”
She swallowed.
“Of all of you.”
That sentence landed harder than accusation.
Then she held out the envelope.
Inside:
Isabella’s handwritten note.
If these devices are ever turned on again, tell Vincent. I don’t care what Harrison says. The boys get headaches when the sweet smell starts.
Vincent read it twice.
Then a second line:
Matteo keeps calling this an investment. They are our children, not a site.
Claire looked at him.
The dead woman had already solved the moral part years ago.
Nobody had listened long enough to keep her order alive.
The investigators also pulled Isabella’s old emails from a family archive.
Most were ordinary.
School applications.
Birthday plans.
A complaint about a gardener pruning roses too aggressively.
Then Aurelia.
One message to Blake:
The boys say the rooms smell “sweet” at night. You keep calling this harmless, but neither of them had headaches before the system.
Blake replied:
Correlation is not causation.
A scientifically reasonable sentence.
Used badly.
Isabella answered:
Then prove it is safe before we keep using it.
That was the correct direction of responsibility.
The burden should not have been on children to become sick enough to prove danger.
Then another email to Matteo:
You keep talking about residential data. Stop. This is our home.
Matteo replied:
You’re overreacting. Harrison is monitoring everything.
Vincent read the exchange.
His wife had been treated the way powerful families often treat the person who makes everyone uncomfortable.
Emotional.
Difficult.
Overprotective.
Words that can be true sometimes and weaponized other times.
Then one more message:
If I am wrong, I will be happy to be wrong. Turn it off first.
Vincent closed the laptop.
Claire later read the approved excerpts with Isabella’s estate counsel.
She said:
“She wasn’t anti-science.”
“No.”
“She wanted consent and precaution.”
“Yes.”
Vincent looked almost defensive on Isabella’s behalf.
Then he stopped.
Isabella did not need him to defend her now.
May you like
She needed the record to show what she had actually said.
That was different.
